General Information of Drug Therapeutic Target (DTT) (ID: TT5A4DX)

DTT Name Beta-adrenergic receptor kinase 2 (ADRBK2)
Synonyms G-protein-coupled receptor kinase 3; Beta-ARK-2; BARK2; ADRBK2
Gene Name GRK3
DTT Type
Literature-reported target
[1]
UniProt ID
ARBK2_HUMAN
TTD ID
T57174
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
EC 2.7.11.15
Sequence
MADLEAVLADVSYLMAMEKSKATPAARASKRIVLPEPSIRSVMQKYLAERNEITFDKIFN
QKIGFLLFKDFCLNEINEAVPQVKFYEEIKEYEKLDNEEDRLCRSRQIYDAYIMKELLSC
SHPFSKQAVEHVQSHLSKKQVTSTLFQPYIEEICESLRGDIFQKFMESDKFTRFCQWKNV
ELNIHLTMNEFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER
IMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE
IILGLEHMHNRFVVYRDLKPANILLDEHGHARISDLGLACDFSKKKPHASVGTHGYMAPE
VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDTFSPE
LKSLLEGLLQRDVSKRLGCHGGGSQEVKEHSFFKGVDWQHVYLQKYPPPLIPPRGEVNAA
DAFDIGSFDEEDTKGIKLLDCDQELYKNFPLVISERWQQEVTETVYEAVNADTDKIEARK
RAKNKQLGHEEDYALGKDCIMHGYMLKLGNPFLTQWQRRYFYLFPNRLEWRGEGESRQNL
LTMEQILSVEETQIKDKKCILFRIKGGKQFVLQCESDPEFVQWKKELNETFKEAQRLLRR
APKFLNKPRSGTVELPKPSLCHRNSNGL
Function Specifically phosphorylates the agonist-occupied form of the beta-adrenergic and closely related receptors.
KEGG Pathway
Chemokine signaling pathway (hsa04062 )
Endocytosis (hsa04144 )
Hedgehog signaling pathway (hsa04340 )
Glutamatergic synapse (hsa04724 )
Olfactory transduction (hsa04740 )
Morphine addiction (hsa05032 )
Reactome Pathway
Cargo recognition for clathrin-mediated endocytosis (R-HSA-8856825 )
G alpha (s) signalling events (R-HSA-418555 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Investigative Drug(s) Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID21596927C101 DM7JRHB Discovery agent N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol Pharmacol. 2011 Aug;80(2):294-303.